Novel cellular therapies for hepatobiliary malignancies.
Xue JN, Wang YY, Wang YC, Zhang N, Zhang LH, Lu ZH, Zhao LJ, Zhao HT.
Xue JN, et al. Among authors: lu zh.
Hepatobiliary Pancreat Dis Int. 2022 Oct;21(5):450-454. doi: 10.1016/j.hbpd.2022.08.014. Epub 2022 Sep 6.
Hepatobiliary Pancreat Dis Int. 2022.
PMID: 36100543
Review.